Aelis Farma SA (EPA:AELIS)
0.8750
-0.0090 (-1.02%)
Oct 2, 2026, 4:31 PM CET
Aelis Farma Revenue
Aelis Farma had revenue of 450.00K EUR in the half year ending June 30, 2026, a decrease of -89.09%. This brings the company's revenue in the last twelve months to 2.19M, up 23.15% year-over-year. In the year 2025, Aelis Farma had annual revenue of 2.08M, down -62.53%.
Revenue (ttm)
2.19M
Revenue Growth
+23.15%
P/S Ratio
5.43
Revenue / Employee
137.00K
Employees
16
Market Cap
11.90M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.08M | -3.48M | -62.53% |
| Dec 31, 2024 | 5.56M | -6.80M | -54.99% |
| Dec 31, 2023 | 12.36M | 3.99M | 47.75% |
| Dec 31, 2022 | 8.36M | -2.40M | -22.28% |
| Dec 31, 2021 | 10.76M | 9.63M | 846.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 26.03M |
| Nicox | 16.77M |
| Poxel | 7.66M |
| Advicenne | 6.50M |
| MaaT Pharma | 3.18M |
| Oncodesign Precision Medicine Société anonyme | 1.81M |
| Aton | 661.00K |
| TME Pharma | 27.00K |